Fate Therapeutics, Inc. (FATE)
1.94
+0.10
(+5.72%)
USD |
NASDAQ |
Nov 09, 16:00
1.94
0.00 (0.00%)
Pre-Market: 20:00
Fate Therapeutics Cash and Short Term Investments (Quarterly) : 139.13M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 139.13M |
| June 30, 2026 | 153.77M |
| March 31, 2026 | 174.82M |
| December 31, 2025 | 203.66M |
| September 30, 2025 | 215.42M |
| June 30, 2025 | 222.83M |
| March 31, 2025 | 240.42M |
| December 31, 2024 | 279.07M |
| September 30, 2024 | 296.92M |
| June 30, 2024 | 304.88M |
| March 31, 2024 | 383.54M |
| December 31, 2023 | 315.18M |
| September 30, 2023 | 349.73M |
| June 30, 2023 | 377.94M |
| March 31, 2023 | 408.90M |
| December 31, 2022 | 436.23M |
| September 30, 2022 | 505.14M |
| June 30, 2022 | 568.85M |
| March 31, 2022 | 573.77M |
| December 31, 2021 | 615.91M |
| September 30, 2021 | 678.70M |
| June 30, 2021 | 695.60M |
| March 31, 2021 | 790.14M |
| December 31, 2020 | 482.92M |
| September 30, 2020 | 488.80M |
| Date | Value |
|---|---|
| June 30, 2020 | 533.41M |
| March 31, 2020 | 203.28M |
| December 31, 2019 | 221.43M |
| September 30, 2019 | 302.82M |
| June 30, 2019 | 162.01M |
| March 31, 2019 | 183.03M |
| December 31, 2018 | 201.01M |
| September 30, 2018 | 211.19M |
| June 30, 2018 | 78.02M |
| March 31, 2018 | 88.63M |
| December 31, 2017 | 100.95M |
| September 30, 2017 | 69.21M |
| June 30, 2017 | 71.01M |
| March 31, 2017 | 82.30M |
| December 31, 2016 | 92.11M |
| September 30, 2016 | 46.62M |
| June 30, 2016 | 45.93M |
| March 31, 2016 | 55.61M |
| December 31, 2015 | 64.81M |
| September 30, 2015 | 72.86M |
| June 30, 2015 | 81.18M |
| March 31, 2015 | 42.35M |
| December 31, 2014 | 49.10M |
| September 30, 2014 | 45.53M |
| June 30, 2014 | 42.01M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AVITA Medical, Inc. | 10.50M |
| Agenus, Inc. | 86.94M |
| Amgen, Inc. | 13.19B |
| Anika Therapeutics, Inc. | 44.96M |
| BioCryst Pharmaceuticals, Inc. | 375.52M |